FDA
approval
· 2025-10-06
FDA Approved: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approves Camber Pharmaceuticals' generic triple-combination tablet of olmesartan medoxomil, amlodipine, and hydrochlorothiazide for essential hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE)